SCHEMBL18744672

SCHEMBL18744672

CCCC(N)c1oc2ccccc2c1C(=O)c1ccc(O)c(C(F)(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EYA3 Q99504 11/20 0.43
▸ SLC22A12 Q96S37 2/20 0.42
▸ PTPN1 P18031 2/20 0.42
▸ CYP2C19 P33261 6/20 0.40
▸ CYP2C9 P11712 5/20 0.39
▸ TTR P02766 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ ABCB11 O95342 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ PGR P06401 2/20 0.38
▸ ADRA2A P08913 2/20 0.38
▸ TBXA2R P21731 2/20 0.38
▸ OPRM1 P35372 2/20 0.38
▸ SLC6A3 Q01959 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ BIRC5 O15392 1/20 0.38
▸ HTR1A P08908 1/20 0.38
▸ DRD1 P21728 1/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ SLC6A2 P23975 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18744679 0.83 EYA3 (0.39) EYA3SLC22A12PTPN1CYP2C19CYP2C9
SCHEMBL18744673 0.81 SIRT3 (0.46) CYP2C19CYP2C9MEN1ABCB11LMNA
SCHEMBL18744671 0.80 KDM5A (0.46) EYA3CYP2C9TTRMEN1ABCB11
SCHEMBL18744670 0.79 KDM5A (0.53) EYA3CYP2C9MEN1ABCB11LMNA
SCHEMBL18744668 0.79 EYA3 (0.62) EYA3SLC22A12PTPN1CYP2C19CYP2C9
SCHEMBL15313203 0.78 EYA3 (0.67) EYA3SLC22A12PTPN1TTRTHRB
SCHEMBL18744699 0.76 KDM5A (0.60) CYP2C9MEN1ABCB11LMNAADRA2A
SCHEMBL29286594 0.69 EYA3 (0.70) EYA3SLC22A12PTPN1CYP2C19CYP2C9
SCHEMBL29286596 0.68 SIRT1 (0.47) MEN1LMNAKMT2AALDH1A1MAPT
SCHEMBL11555712 0.67 EYA3 (0.55) EYA3SLC22A12PTPN1CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9895340-B2 Fluorinated benzofuran derivatives SCIFLUOR LIFE SCIENCES, INC. (US) 2018-02-20 — — US disclosed
US-20170189370-A1 FLUORINATED BENZOFURAN DERIVATIVES FELIQS CORPORATION (JP) 2017-07-06 — — US disclosed
EP-2838890-B1 FLUORINATED BENZOFURAN DERIVATIVES SCIFLUOR LIFE SCIENCES INC (US) 2017-06-21 — — EP disclosed
US-9624189-B2 Fluorinated benzofuran derivatives SCIFLUOR LIFE SCIENCES, INC. (US) 2017-04-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170189370-A1 FLUORINATED BENZOFURAN DERIVATIVES FABP3, TNNI3, TNNT2 EYA3 3283/4885SLC22A12 1678/4885PTPN1 4361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback